SECsense Logo

Vertex Pharmaceuticals Inc. 8-K Report: Key Updates from August 4, 2025

$VRTX
Form 8-K
Filed on: 2025-08-04
Source
Vertex Pharmaceuticals Inc. 8-K Report: Key Updates from August 4, 2025

Based on the provided section of the financial report, here are the key insights extracted:

  1. Entity Information:
  • Company Name: Vertex Pharmaceuticals Inc.
  • CIK Number: 0000875320
  • Location: 50 Northern Avenue, Boston, MA 02210
  • Contact Number: 617-341-6100
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: August 4, 2025
  • SEC File Number: 000-19319
  • IRS Employer Identification Number: 04-3039129
  1. Securities Information:
  • Security Type: Common Stock
  • Par Value: $0.01 per share
  • Stock Ticker: VRTX
  • Exchange: NASDAQ
  1. Date Range for Report:
  • Period Covered: The report is for a single date, August 4, 2025, indicating that it may be reporting a specific event or announcement occurring on that date.
  1. Namespaces and Schema:
  • The XML adheres to XBRL (eXtensible Business Reporting Language) standards, which is used for electronic financial reporting to improve the accessibility and comparability of financial information.

Overall Insights: This section indicates that Vertex Pharmaceuticals is filing an 8-K report, which is typically used to report major events that shareholders should know about. The filing date being the same as the report period suggests that it may be disclosing a significant event or development on that particular day. The mention of common stock and the associated financial details indicates the company's ongoing financial reporting obligations and its status as a publicly traded company on NASDAQ.